Transcriptional and metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages. by Arts, R.W. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/171836
 
 
 
Please be advised that this information was generated on 2019-06-01 and may be subject to
change.
ORIGINAL RESEARCH
Transcriptional and metabolic reprogramming induce an inﬂammatory phenotype in
non-medullary thyroid carcinoma-induced macrophages
Rob J. W. Arts a,*, Theo S. Plantinga b,*, Sander Tuit c, Thomas Ulas c, Bas Heinhuisa, Marika Tesselaarb,
Yvette Slootd, Gosse J. Adema e, Leo A. B. Joosten a, Johannes W. A. Smitd, Mihai G. Netea a,
Joachim L. Schultze c,f, and Romana T. Netea-Maier d
aDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands;
bDepartment of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands; cGenomics and Immunoregulation, LIMES-Institute,
University of Bonn, Bonn, Germany; dDepartment of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, the
Netherlands; eDepartment of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the
Netherlands; fGerman Center for Neurodegenerative Diseases, Bonn, Germany
ARTICLE HISTORY
Received 1 August 2016
Revised 20 August 2016
Accepted 22 August 2016
ABSTRACT
Tumor-associated macrophages (TAMs) are key components of the tumor microenvironment in non-
medullary thyroid cancer (TC), the most common endocrine malignancy. However, little is known
regarding the regulation of their function in TC. Transcriptome analysis in a model of TC-induced
macrophages identiﬁed increased inﬂammatory characteristics and rewiring of cell metabolism as key
functional changes. This functional reprogramming was partly mediated by TC-derived lactate that
induced upregulation of cytokine production through an AKT1/mTOR-dependent increase in aerobic
glycolysis. This led to epigenetic modiﬁcations at the level of histone methylation, and subsequently long-
term functional changes. Immunohistochemistry assessment validated the increase in glycolysis enzymes
and lactate receptor in TAMs in tissue samples from patients with TC. In conclusion, Akt/mTOR-dependent
glycolysis mediates TC-induced reprogramming of TAMs and inﬂammation, and this may represent a
novel therapeutic target in TC.
Abbreviations: BC-PAP, papillary TC, BRAF V600E mutation; CRA, co-regulation analysis; ECAR, extracellular acidiﬁca-
tion rate; FTC133, follicular TC, PTEN deﬁcient; H3K4me3, histone 3 lysine 4 trimethylation; HIF1, hypoxia inducible
factor; IFN, interferon; IL, interleukin; LPS, lipopolysaccharide; OCR, oxygen consumption rate; PBMC, peripheral
blood mononuclear cell; RPMI, Roswell park memorial institute culture medium; SNP, single nucleotide polymor-
phism; TAM, tumor-associated macrophage; TC, thyroid cancer; TLR, Toll-like receptor; TNF, tumor necrosis factor;
TPC1, papillary TC with a RET/ PTC rearrangement; TR, transcriptional regulator; VEGF, vascular epithelial growth
factor
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Introduction
Tumor-associated macrophages (TAMs) and cancer cells have
an important mutual relationship: on the one hand, the tumor
modulates the function of inﬁltrating macrophages, and thus
contributes to reprogramming of TAMs, while on the other
hand TAMs inﬂuence the behavior of cancer cells.1 Theoreti-
cally, macrophages have the potential to play an effective role
in elimination of tumor cells; however, there are also important
lines of evidence that TAMs promote cancer cell survival, pro-
liferation, metastases, angiogenesis, and immune suppression.2
The impact of TAMs on tumor progression very likely depends
on their speciﬁc reprogramming within the tumor, a process
inﬂuenced by factors of the local microenvironment such as
hypoxia, release of local mediators (e.g., cytokines, growth fac-
tors), as well as metabolic products released by either the cancer
cells and/or other immune and stroma cells.1-4 The pathways
and mechanisms involved in the reprogramming of TAMs are
incompletely understood and in the present study, we aimed to
investigate the phenotypic and functional characteristics of
TAMs in a model of non-medullary thyroid cancer (TC). TC is
the most common endocrine malignant tumor and of all cancer
types has the highest rise in incidence.5 Previous studies have
shown that particularly anaplastic and poorly differentiated
TCs, which have a very poor prognosis, are highly inﬁltrated
with TAMs and that this correlates with prognosis. In these
tumors, TAMs represent the most prominent component of
the tumor microenvironment.6,7 Pharmacological depletion of
TAMs using CSF-1R inhibition in a murine model of TC has
been reported to reduce tumor development and progression.8
These data suggest that TAMs have pro-tumorigenic effects in
TC and might represent promising therapeutic targets for
tumors that are resistant to conventional treatment.
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Nevertheless, little is known about on the role of the TAMs in
TC and on the factors driving the functional reprograming the
macrophages within the context of TC. To this end, we used a
complementary approach that combines a discovery-based
methodology on transcriptome analysis of human monocytes
that have been co-cultured with TC cells and differentiated into
TC-induced macrophages to reveal essential pathways in spe-
ciﬁc reprogramming of these macrophages, with immunologi-
cal, metabolic, and genetic approaches to validate the pathways
identiﬁed. We show that TC-induced macrophages are charac-
terized by important immunological and metabolic rewiring
that impacts their function and that these metabolic changes
are being recapitulated in the TAMs in tissue samples from
patients with TC. These ﬁndings may help the identiﬁcation of
novel therapeutic approaches for TC and potentially for other
malignant processes as well.
Results
Transcriptome analysis: Inﬂammatory and metabolic
rewiring in TC-induced human macrophages
To enable a detailed analysis of the effect of TC cells on mono-
cyte reprogramming, we generated genome-wide transcriptome
data by RNA-sequencing of TC-induced macrophages and
RPMI cultured control monocytes (24 h of culture), both of
which were relieved for either 4 h or 24 h in RPMI after co-cul-
ture with the tumor cells (TPC1 cell line). We performed an
extensive bioinformatics analysis as outlined in (Fig. 1A). A
total of 13,047 transcripts were identiﬁed as present throughout
4 conditions represented by 16 samples. Employing a two-way
ANOVA model (Table S1), we identiﬁed 372 (4 h) and 353
(24 h) genes being differentially expressed between TC-induced
macrophages and RPMI controls (Fig. S1A). Next, we visual-
ized the degree of variance between TPC1 co-cultured mono-
cytes and control cells at both time points by performing
hierarchical clustering (HC) based on the top 1,000 variable
genes (Fig. 1B). HC revealed that TPC1 co-cultured monocytes
exert signiﬁcant transcriptomic changes compared to control
monocytes. Moreover, there was also a clear difference in gene
expression between monocytes co-cultured with TPC1 for 4 h,
respectively, 24 h, suggesting that the observed changes are
dynamic. To validate these ﬁndings, we applied co-regulation
analysis (CRA) and visualized the gene network of the top 500
variable genes within the data (Fig. 1C). The topology of the
network was deﬁned by two major clusters (C1, C2), with clus-
ter C1 showing a clear substructure (C1a, C1b). Overlaying dif-
ferentially regulated genes onto the network revealed that the
cluster C1a represented genes increased in expression in mono-
cytes co-cultured with TPC1 at the 4 h time point, while C1b
was associated with genes elevated at the 24 h time point. Addi-
tionally, employing Self-Organizing Map (SOM) clustering to
identify and visualize conditions-speciﬁc genes within the net-
work (Fig. S1B), we were able to validate the condition-speciﬁc
sub-networks. Together, these data support a model suggesting
transcriptional programming of monocytes by TPC1 tumor
cells in a dynamic fashion. To investigate the biological rele-
vance of the observed transcriptomic changes in both 4 h and
24 h TC-induced macrophages, we applied Gene Set
Enrichment Analysis (GSEA) using two well-established path-
way gene sets.9 Computing enrichment for hallmark pathways
(Fig. 1D), “PI3K/AKT/MTOR,” and “fatty acid metabolism”
pathways were enriched at the 4 h time point. In contrast, the
TPC1 co-cultured monocytes taken at the 24 h time point
showed enrichment of “interferon gamma response” and
“angiogenesis” related pathways. Using reactome pathways to
compute enrichment, we detected even more inﬂammation-
related pathways to be enriched at the 24 h time point (e.g.,
inﬂammasome activation, TLR responses, interferon signaling,
etc.) (Fig. S1C, Table S2). It is known that cellular metabolism
of macrophages is crucial for inﬂammatory function, with a
shift from oxidative phosphorylation toward mTOR-dependent
aerobic glycolysis playing a central role.10,11 Therefore, we
extracted the gene sets from PI3K/AKT/mTOR- and glycolysis-
related pathways (both hallmark and reactome) and mapped
them onto the CRA network (Fig. 1E). Indeed 16 of 23 genes
were found in cluster C1 (Fig. 1E) and were elevated at the 4 h
(12/16) and 24 h (10/16) time points, respectively (Table S3).
To determine whether potential transcriptional regulators (TR)
of mTOR-dependent aerobic glycolysis might also be part of
the network, we mapped TR information onto the CRA net-
work (Fig. S1D). Surprisingly, 23 TRs were downregulated
(cluster C2) in TPC1 co-cultured monocytes, while only seven
TRs were upregulated. Indeed, among the upregulated tran-
scription factors, we identiﬁed hypoxia-inducible factor-1 a
(HIF1A, orange node), which was previously shown to be
involved in mTOR-dependent aerobic glycolysis 10 in cluster
C1a. RelA, a NF-kB transactivating subunit that has been
shown to counteract reprogramming to aerobic glycolysis 12
was found to be downregulated in TPC1 co-cultured mono-
cytes. Moreover, the reactome pathway “NF-kB is activated and
signals survival” was found to be depleted in TPC1 co-cultured
monocytes at the 4 h time point (Fig. S1C). We next validated
the ﬁndings for the 24 h time point employing Gene Ontology
Enrichment Analysis (GOEA) on genes elevated in TPC1 co-
cultured monocytes (fold change (FC) over mean:  1, present
in the CRA network). Network visualization of enriched GO-
Terms revealed terms related to “immune cell proliferation”
and “activation of innate immune response” (Fig. 1F) further
supporting reprogramming of monocytes at the later time
points toward immune activation. Taken together, our data
analysis supported a model of transcriptional regulation of
genes involved in mTOR-dependent glycolysis early after expo-
sure to TC cells, while further reprogramming toward an
inﬂammatory response was seen at the later time point.
TC-induced macrophages are reprogrammed by the
secretome of TC cells
Transcriptome analysis suggested a proinﬂammatory proﬁle
of TC-induced macrophages. We aimed to validate this
ﬁnding by functional assessments: human primary mono-
cytes were co-incubated in a trans-well system with the
three types of TC cell lines (TPC1, FTC133, and BC-PAP)
for 24 h, followed by restimulation for 24 h with either cul-
ture medium (RPMI), or Toll-like receptor (TLR) ligands
(TLR4 ligand lipopolysaccharide (LPS), TLR2 ligand
(Pam3CKS4 (P3C), or IL-1a) (Fig. 2A). The production of
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Figure 1. Transcriptome analysis of TC-induced macrophages. (A) Scheme outlining the experimental setup (upper scheme) and bioinformatics analysis (lower scheme).
(B) HC map of the top 1,000 variable genes between TC-induced macrophages and RPMI controls. (C) Network visualization of gene-centered CRA (Pearson correlation 
0.7). FC over mean of all conditions is mapped onto the network for TC-induced macrophages (4 h, left network; 24 h, right network). (D) Volcano plots of normalized
enrichment scores (NES) and enrichment p-values based on GSEA using Hallmark pathway gene sets (MSigDB, Broad Institute). Data are shown for TPC1 co-cultured mac-
rophages (4 h and 24 h). Dark (NES  1; p-value  0.05) and light (NES  1; p-value > 0.05,  0.1) red circles show gene sets positively enriched. Dark and light blue
circles show gene sets depleted (NES  ¡1). (E) Hallmark and reactome pathway genes (MSigDB, Broad institute) related to PI3K/AKT/MTOR and glycolysis mapped onto
the CRA network (orange nodes). (F) Network visualization of GOEA of genes derived from the “TPC1 co-cultured (24 h) vs. mean all conditions” comparison (FC:  1; pres-
ent in CRA network) using BiNGO and EnrichmentMap. Red nodes represent the enriched GO-terms, node size and color represents corresponding FDR-adjusted enrich-
ment p-values (p-value  0.05). See also Fig. S1.
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TNF and IL-6 by TC-induced macrophages was signiﬁcantly
increased compared to the control na€ıve macrophages
(Fig. 2B and Fig. S2A). Production of IL-10 and IL-1b was
low and in most conditions below detection limit. Addi-
tional experiments using TPC1-induced macrophages
showed also increased IL-8 production, whereas no differen-
ces in granulocyte macrophage colony-stimulating factor
(GM-CSF), monocyte chemotactic protein 1 (MCP1) were
found (Fig. S2B). Co-culture of human monocytes with two
glioblastoma cell lines showed less strongly upregulated
cytokine production upon restimulation, suggesting a degree
of speciﬁcity for the effect of the TC cell lines (Fig. 2C).
The identiﬁcation of the proinﬂammatory proﬁle induced by
TC cells in monocytes lead to the hypothesis that soluble fac-
tors released by TC cells impact on the differentiation of these
monocytes into macrophages with a speciﬁc phenotype. To
reveal whether a soluble factor in the medium produced by the
cancer cells was responsible for the upregulated cytokine pro-
duction, medium from TC cell line cultures was added to
human monocytes for 24 h, after which cells were restimulated
with LPS. In line with previous experiments, this increased pro-
duction of cytokines from macrophages as well (Fig. 2D). Two
factors known to be released by tumor cells and which have
immunologic effects are vascular epithelial growth factor
(VEGF) and lactate, the end-metabolite of glycolysis. Indeed,
both VEGF (Fig. 2E) and lactate (Fig. 2F) concentrations were
signiﬁcantly increased in TC conditioned media. In order to
determine whether lactate or VEGF could serve as soluble fac-
tors that are necessary for the speciﬁc reprogramming of the
TC-induced macrophages, antagonists of the cellular receptors
for these molecules were added to the culture system. Blockade
of lactate receptor signiﬁcantly reduced cytokine release by TC-
induced macrophages, while blockade of the VEGF receptor
had no effects on cytokine release (Fig. 2G and Fig. S3). These
data suggest that TC cell-derived lactate contributed to the
induction of the inﬂammatory proﬁle of TC-induced macro-
phages. In line with this, preincubation for 24 h with 1 mM of
lactate also increased cytokine production upon TLR stimula-
tion (Fig. 2H).
TC-induced macrophages display increased glucose
metabolism that is necessary for increased cytokine
production
Transcriptome analysis of TC-induced macrophages also
revealed that several metabolic pathways were upregulated at
transcriptional level. We and others have shown that cellular
metabolism of macrophages is crucial for their inﬂammatory
function, with a shift from oxidative phosphorylation toward
mTOR-dependent aerobic glycolysis (Warburg effect) playing a
central role.10,11 To investigate the activation of glycolysis and
oxidative phosphorylation in TC-induced macrophages, extra-
cellular acidiﬁcation rate (ECAR), and oxygen consumption
rate (OCR) of TC-induced macrophages (before restimulation
by TLR engagement) were measured by Seahorse technology.
Interestingly, maximal ECAR was increased in TC-induced
macrophages and OCR was increased at both basal and maxi-
mal level (Fig. 3A). The intracellular concentration of acetyl
CoA was increased, which could be used both to fuel the TCA
cycle and for fatty acid synthesis. The glutamate concentration
was decreased, likely caused by the replenishment of the TCA
cycle through glutamine metabolism (Fig. S4). These data dem-
onstrate strong activation of metabolic activity in the TC-
induced macrophages.
To assess which of the metabolic pathways is essential in the
upregulation of cytokine production, speciﬁc metabolic path-
ways were inhibited and cytokine production was assessed.
Inhibition of the pentose phosphate pathway (6-aminonicoti-
namide, 6-AN), glutamine metabolism (BPTES), b oxidation of
fatty acids (etomoxir), or the electron transport chain complex
V (oligomycin) did not inﬂuence cytokine production. How-
ever, exposure to mTOR inhibitor rapamycin signiﬁcantly
decreased IL-6 production by TC-induced macrophages, dem-
onstrating a role for mTOR/glycolysis pathway in this process
(Fig. 3B and Fig. S5). This was further supported by assessing
phosphorylation of mTOR and its downstream products (S6K
and 4EBP1) in TC-induced macrophages before restimulation.
Indeed, we observed enhanced activation of this pathway in
TC-induced macrophages (Fig. 3C).
In order to validate activation of glycolysis in TC-derived
TAMs in patients with TC, formalin-ﬁxed parafﬁn-embedded
(FFPE) tissue sections of six thyroid tumors were immunohis-
tochemically prepared and TAMs were stained by CD68 stain-
ing. To investigate the extent of glycolysis in these TAMs,
expression of the third human isoform of 6-phosphofructo-2-
kinase/fructose-2,6-bisphosphatase and pyruvate kinase 2
(PFKFB3, PKM2), and the lactate receptor GRP81 were deter-
mined. Both these key enzymes of glycolysis and the expression
of the lactate receptor were highly upregulated in at least 80%
of CD68-positive TC-associated macrophages present in these
tissues. (Fig. 3D and Fig. S6A). In contrast, virtually no macro-
phages could be detected in normal thyroid tissues from the
same individuals (Fig. S6B).
TC-induced macrophages undergo epigenetic
reprogramming regulated by the mTOR pathway
In the following set of experiments, we wanted to assess
whether TC cell-macrophage co-incubation induced a stable
inﬂammatory phenotype over time. To assess this, after the ini-
tial preincubation with TPC1 cells, the TC-induced macro-
phages were left in culture medium for an additional 24 h
before restimulation (Fig. 4A). The restimulation with LPS
showed that the cytokine production was still upregulated in
the TC-induced macrophages even if they were relieved from
the TPC1 cells, demonstrating a long-term stable phenotype
(Fig. 4B). This suggests a putative epigenetic rewiring of the
transcriptional program, as shown in other types of long-term
functional reprogramming of macrophages, for example, dur-
ing trained immunity.13 In order to test this hypothesis, a broad
histone methylation inhibitor (MTA) was added during the
ﬁrst 24 h of co-culture. This brought cytokine production back
to baseline (Fig. 4C), showing that histone methylation plays
an important role in the speciﬁc reprogramming of TC-induced
macrophages. H3K4me3 is an important histone marker of
open (accessible) promoters shown to be associated with high
cytokine production.14 To assess whether increased H3K4me3
plays a role in the long-term inﬂammatory phenotype of TC-
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Figure 2. TC-induced macrophages have a proinﬂammatory phenotype. (A) Outline of the culturing methods. (B) Monocytes were incubated for 24 h with TC cells in a
trans-well system and restimulated with LPS for 24 h (n D 7). (C) TAMs derived from co-culture with TPC1 and two glioblastoma cell lines were restimulated with LPS for
24 h (n D 4). (D) Medium from three thyroid cell lines was added to human monocytes for 24 h and subsequently stimulated with RPMI or LPS for 24 h (n D 4). (E & F)
Lactate and VEGF were determined in na€ıve macrophage and tumor medium (n D 6). (G) A lactate receptor antagonist was added to the culture system. (Mean § SEM,
n D 5, p < 0.05, by Wilcoxon signed-rank test). (H) Monocytes were incubated with 1 mM of lactic acid for 24 h and restimulated with LPS for 24 h (n D 8). Data shown
as Mean § SEM, p < 0.05, p < 0.01 by Wilcoxon signed-rank test.
ONCOIMMUNOLOGY e1229725-5
Figure 3. Metabolism of TC-induced macrophages is changed. (A) Extracellular acidiﬁcation rate (ECAR) and oxygen consumption rate (OCR) from TC-induced macro-
phages and naive macrophages were determined after TC-induced macrophages were relieved for 24 h from the TPC1 cells (n D 4). (B) Inhibitors of mTOR (rapamycin),
pentose phosphate pathway (6-AN), glutamine metabolism (BPTES), fatty acid b oxidation (etomoxir), and complex V ATP synthase (oligomycin) were added to the cul-
ture system and cells were restimulated for 24 h with LPS (n D 4). (C) Monocytes were incubated for 24 h with TPC1 cells, after 24 h rest cells were lysed and p-mTOR,
p-S6K, and p-4EBP1 induction were determined. (D) Immunohistochemical analysis of PFKFB3, PKM2, and GPR81 in CD68-positive TAMs. Results are representative of
stained FFPE tissue material from six anaplastic TC patients. Data shown as Mean § SEM, p < 0.05, by Wilcoxon signed-rank test.
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Figure 4. The proinﬂammatory phenotype is epigenetically regulated. (A) Outline of the culturing methods. (B) Monocytes were co-incubated with thyroid tumor cell
lines for 24 h. After 1 day additional rest they were restimulated with LPS for 24 h (n D 5). (C) MTA, an inhibitor of histone methylation was added to the culture system
and cells were restimulated for 24 h with LPS (n D 6). (D & E) Monocytes were incubated for 24 h with TPC1 cells, after 24 h rest DNA was isolated to determine
H3K4me3 (D) and H3K9me3 (E) expression at the promoter site of IL6 and TNFA (n D 6, nD 5). Data shown as Mean § SEM, p < 0.05 by Wilcoxon signed-rank test.
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associated macrophages, monocytes were preincubated for 24 h
with TPC1 cells, after which the tumor cells were removed and
the macrophages were incubated for an additional 24 h in cul-
ture medium. Chromatin immunoprecipitation was performed
to determine the H3K4me3 status of the promoters of IL6 and
TNFA in TC-induced macrophages. Indeed, a signiﬁcant
increase of H3K4me3 was observed in the TC-induced macro-
phages. Additionally, when rapamycin was added to the culture
medium, the increase of H3K4me3 was abolished, which corre-
sponded to the observed decrease of IL-6 after mTOR inhibi-
tion with rapamycin (Fig. 4D). This suggested that the
induction of the mTOR-dependent pathway plays an important
role for long-term epigenetic reprogramming of TC-induced
macrophages. H3K9me3 is a histone mark that induces hetero-
chromatin and therefore decreases DNA accessibility14, which
was also found to be important in trained immunity.15 A
potential role of H3K9me3 was assessed, but no signiﬁcant
downregulation of H3K9me3 was found after co-culture with
TPC1 tumor cells (Fig. 4E).
Discussion
The process through which monocytes inﬁltrate tumors, differ-
entiate into TAMs, and inﬂuence the immune responses
toward the malignant cells is believed to play a crucial role in
carcinogenesis. TC is the most common endocrine malignancy,
and TAMs have been shown to be strongly present in the
tumor and impact the prognosis.6,7 However, despite this, very
little is known about the phenotype of TAMs in TC and the
pathways that inﬂuence macrophage differentiation in TC. In
the present study, we initiated transcriptome analysis of TC-
induced macrophages, and we demonstrate that soluble factors
released by TC (among which lactate) induce a strong inﬂam-
matory phenotype and a rewiring of the cellular metabolism of
TC-induced macrophages. Activation of mTOR-dependent gly-
colysis induced long-term epigenetic histone modiﬁcations
(especially H3K4me3) and upregulated cytokine production.
The role of the lactate-glycolysis-inﬂammation circuit for TC
was also further supported in patients through immunohisto-
logical and genetic approaches.
The assessment of the transcriptome of the TC-induced
macrophages identiﬁed complex circuits of immunological and
metabolic pathways. One of the strongest set of cellular func-
tions highly upregulated in the TC-induced macrophages were
those related to inﬂammation: pathways related to pattern-rec-
ognition receptors, chemokine synthesis, and cytokine–cyto-
kine receptor interaction were upregulated, suggesting a strong
inﬂammatory phenotype of the cells. This was validated by
experiments demonstrating that macrophages differentiated in
the presence of TC cell lines displayed much stronger inﬂam-
matory function upon stimulation. An inﬂammatory pheno-
type has been demonstrated to characterize TAMs in many
tumors16, and inﬂammation stimulates carcinogenesis through
multiple pathways: excretion of epidermal growth factor,
proangiogenic signals such as VEGF and ﬁbroblast growth fac-
tor 2, several proinﬂammatory cytokines and chemokines, and
factors such as matrix-degrading enzymes, metalloproteinases,
cysteine cathepsin proteases, and heparanases all contribute to
a tumor-promoting environment.17,18 These data strongly
suggest that TAMs-derived inﬂammation has an important
impact on TC development. Indeed, it has been previously
shown that the presence of inﬂammatory mediators in TC,
including cytokines such as IL-1b and TNFa, negatively inﬂu-
ence the expression of sodium iodine symporter, the major pro-
tein responsible for the uptake of radioactive iodide in thyroid
cells which represents the main targeted therapy for patients
with TC.19 Also processes that limit inﬂammation such as auto-
phagy are defective in TC.20,21 In addition to TAMs, also the
function of regulatory T cells has been shown to be dependent
on glycolysis, as the induction of their suppressive function was
tightly dependent on mTOR-induced glycolysis.22 This is espe-
cially interesting as more aggressive forms of TC are associated
with increased numbers of regulatory T cells in peripheral
blood 23 and TAMs are able to induce regulatory T cells.24,25
The interaction and balance between the proinﬂammatory
macrophages and inhibitory regulatory T cells, whose activity
is both dependent on glycolysis, might therefore be an interest-
ing topic for future research.
In addition to the inﬂammatory pathways induced by TC in
TAMs, a second important set of biological processes strongly
modulated were the metabolic pathways, with strong upregula-
tion of the mTOR signaling pathway, carbohydrate digestion,
but also fatty acid and pyrimidine biosynthesis. Changes in cel-
lular metabolism, and especially a shift toward aerobic glycoly-
sis through mTOR-dependent mechanisms, have been recently
demonstrated to be crucial for the activation of macro-
phages.10,11 Moreover, inﬂammatory (M(IFNg), formely M1)
macrophage metabolism is associated with an increased glucose
consumption and lactate production, whereas the more anti-
inﬂammatory (M(IL4), formally M2) macrophages depend
preferentially on oxidative phosphorylation. On the other
hand, M(IL-4) macrophages typically express more arginase,
which is necessary in amino acid metabolism26,27 and M(IL-4)
macrophages also show more fatty acid uptake and b-oxidation
compared to M(IFNg) macrophages.28 Interestingly, the tran-
scriptome and functional phenotype of TC-induced macro-
phages did not display a clear M(IFNg) or M(IL-4) phenotype,
with both pathway characteristics of M(IFNg) (inﬂammation,
glycolysis) and M(IL-4) (oxidative phosphorylation) being
upregulated. Interestingly, when we compared our results to
the transcriptome of a panel of 29 different macrophage pro-
ﬁles as reported by Xue et al.29, the transcriptional program of
4 h TC-induced macrophages was deﬁned by gene modules
associated with macrophage stimulation by fatty acids (linoleic,
oleic, lauric acid), LPS or a combination of TNF, prostaglandin
E2 and Pam2Cys (TPP). The transcriptional program of 24 h
TC-induced macrophages was mainly described by IL-4
deﬁned gene modules in combination with an inﬂammatory
gene module linked to stimulation with palmitic acid (PA)
(Fig. S1E). Therefore, this mixed gene signature in TC-induced
macrophages cannot be considered as an archetypical M2 mac-
rophage. We thus propose that the functional program induced
by TC in TAMs is distinct and combines elements from both
M(IL-4) macrophages, and inﬂammatory characteristics. In
addition to IL-4, another important anti-inﬂammatory cyto-
kine is IL-37, which could be especially relevant due to its
capacity to inhibit the Akt/mTOR pathway.30,31 While no IL-37
expression could be found in the TC-induced macrophages,
e1229725-8 R. J. W. ARTS ET AL.
future studies should investigate it in in vivo samples from TC
patients.
One of the most relevant ﬁndings of metabolic pathways
activated in TC-induced macrophages is mTOR-dependent gly-
colysis. Indeed, we demonstrate an essential role for the AKT/
mTOR pathway for the inﬂammatory phenotype of the TC-
induced macrophages and this could represent an important
therapeutic target. In TAMs induced by other tumors it has
been shown that lactic acid produced by the cancer cells is
essential for TAM reprogramming, by induction of the tran-
scription factor HIF-1a3, and a similar dependency on lactate
release was observed for the cytokines released in our system.
As HIF-1a activation is highly dependent on mTOR activation,
our observation that HIF-1a is one of the main TFs in TC-
induced macrophages ﬁts with this picture. Interestingly, inhib-
iting mTOR with rapamycin abolished IL-6 upregulation
induced by TC cells, while TNFa production was not affected.
In addition, mTOR inhibition was accompanied by downregu-
lation of the histone marks associated with open chromatin
and increased transcription.
This role of the mTOR pathway provides a link between cel-
lular metabolism and epigenetic programming of gene tran-
scription. The ﬁeld of metabolo-epigenomics is an emerging
ﬁeld within immunology 32, with important roles demonstrated
for various metabolites (especially of glycolysis and TCA cycle)
in modulating epigenetic processes. For examples, acetyl-CoA
inﬂuences histone acetylation by functioning as a substrate for
histone acetylation, succinate and fumarate inhibit histone
demethylases, and NADC induces histone deacetylation
through activation of sirtuins.32-34 Recently, the rate of glycoly-
sis was directly associated with the acetylation of speciﬁc his-
tone sites, which appeared to be mostly dependent on acetyl-
CoA levels.35 We show an upregulation of glycolysis, and an
increased intracellular concentration of acetyl Co-A in TC-
induced macrophages. Moreover, glycolysis has been shown to
be a source (together with folic acid and methionine) for S-
adenosylmethionine (SAM), which serves as a methyl donor
for histone and DNA methylation.33 This is especially interest-
ing because of increased TCA cycle metabolism and oxidative
phosphorylation in TC-induced macrophages. All in all, these
data strongly suggest that the metabolic rewiring induced in
macrophages by TC-derived compounds (such as lactate) indu-
ces epigenetic reprogramming (as demonstrated by enhanced
H3K4me3), which in turn results in increased gene transcrip-
tion of inﬂammatory mediators (see scheme Fig. 5). We
hypothesize that this enhanced inﬂammation will in turn inﬂu-
ence tumor progression and outcome.
In addition to glycolysis, other metabolic pathways were also
modulated in TC-induced macrophages. Interestingly, inhibi-
tion of glutamine metabolism that can contribute to replenish-
ment of the TCA cycle did not reduce cytokine production in
TAMs, but showed a tendency toward increased cytokine pro-
duction. This is an interesting observation, which has not been
further investigated, but should be addressed in future research.
In addition, fatty acid synthesis was very strongly increased in
TC-induced macrophages: although an effect on inﬂammation
and cytokine production was not observed, this may very well
impact other aspects of tumor and macrophage biology such as
cell survival and proliferation.
Our observation that reprogramming of tumor stroma cells
(in our case TAMs) is associated with changes in metabolism is
reminiscent of a process termed “reverse Warburg effect.”36,37
In this process it has been suggested that cancer cells reprogram
metabolism of tumor stroma cells toward aerobic glycolysis
(Warburg effect), and this will result in fuel for mitochondrial
metabolism (e.g., lactate and ketones), which is beneﬁcial for
tumor growth and survival. Using oxidative phosphorylation
instead of glycolysis reduces the speed of cell aging and is there-
fore beneﬁcial for tumor cell survival, growth, and metastasis.37
Whether these changes are a result of local reprogramming of
myeloid cells in the tumor microenvironment or whether solu-
ble factors excreted by the tumor (stroma) already reprogram
circulating monocytes, or even the myeloid precursors in the
bone marrow, remains unanswered and should be investigated
in future studies.
In conclusion, we show that TC-induced macrophages dis-
play broad changes in cellular metabolism and have an
increased inﬂammatory proﬁle. Reprogramming of the TC-
induced macrophages is dependent on activation of the AKT/
mTOR pathway, which is also essential for reshaping the epige-
netic landscape.
Materials and methods
Co-culture model of TC cell lines and human monocytes
The TC cell line in vitro experiments were performed using
TPC1 (papillary, RET/ PTC rearrangement), BC-PAP (papil-
lary, BRAF V600E mutation), and FTC133 (follicular, PTEN
deﬁcient) cell lines.38 The human glioblastoma cell lines U87
and U251 were kindly provided by Prof. G.J. Adema and Dr P.
Gielen, Radboudumc Nijmegen. Peripheral blood mononuclear
cells were isolated by density gradient centrifugation using
Ficoll-plaque (GE Healthcare, Diegem Belgium) from buffy
coats obtained from Sanquin bloodbank, Nijmegen, The
Netherlands, or healthy volunteers after informed consent (eth-
ical approval CMO 2010-104). After adhesion for 1 h in the 96-
well plates, the non-adherent cells comprising mainly lympho-
cytes were discarded, and the adherent monocytes were incu-
bated further with the tumor cell lines. In selected experiments
such as those assessing cell transcriptome, an additional step of
puriﬁcation using CD14-labeled magnetic beads was performed
in order to obtain a highly puriﬁed monocyte population.
The cancer cell lines were grown in culture medium
RPMI 1640 Dutch modiﬁcation (Life Technologies, Carls-
bad, California, USA) supplemented with gentamycin
50 mg/mL, pyruvate 1 mM, glutamax 2 mM and 10% Fetal
Calf Serum (Gibco, Life Technologies). A trans-well system
used ThinCertTM cell culture inserts on a 24-well plate
(Greiner Bio-One GmbH, Austria). Cell counts were per-
formed in a Coulter particle counter (Beckman Coulter
Inc.). A total of 1.0 £ 105 TPC1 cells (or the other TC cell
lines, as indicated) in 250 mL culture medium were added
to the upper compartment of the trans-well system, while
RPMI was added to the lower compartment. The cells were
incubated for 24 h at 37C, 5% CO2. Next, the cells were
washed with Phosphate Buffered Saline (PBS, Braun Mel-
sungen, Germany) and PBMCs were prepared in culture
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medium: RPMI (Life Technologies, Carlsbad, California,
USA) supplemented with glucose 5 mM, pyruvate 1 mM,
glutamine 2 mM, gentamicin 50 mg/mL and HEPES 10 mM
(Life Technologies, Carlsbad, California, USA). A total of
1.0 £ 106 PBMCs in 500 mL were added to the lower com-
partment of the trans-well system. PBMCs and cancer cell
lines were co-cultured for 24 h at 37C. In some experi-
ments, the mTOR inhibitor rapamycin (100 nM, Bio Con-
nect, Huissen, The Netherlands), glutaminase inhibitor
BPTES (50 mM, Sigma – Aldrich Chemie, Zwijndrecht, The
Netherlands,), G6PD inhibitor 6-aminonicotinamide
(100 nM, Sigma), CPT-1 inhibitor etomoxir (10 mM,
Sigma), ATP synthase inhibitor oligomycin (1 mM, Sigma),
500 mm 50-deoxy-50(methylthio) adenosine (MTA, sigma),
lactate receptor antagonist a-cyano-4-hydrocycinnamioic
acid (1 mM, Sigma) or VEGF receptor antagonist Sorafenib
(100 nM, Bio Connect) were added to the medium.
After 24 h incubation, the cell culture inserts containing
RPMI control medium or TPC1 cells were discarded and the
PBMCs were stimulated for 24 h with RPMI or 10 ng/mL LPS
(E. coli strain O55:B5, Sigma Chemical Co, St. Louis, MO), as
substitute for endogenous TLR4 ligand signaling, 10 mg/mL
Pam3Cys (EMC microcollection) or 10 ng/mL IL-1a
(Hoffman/Roche). At the end of the incubation period, super-
natant was collected and stored at ¡20C until further analysis,
or cells were collected for further analysis.
RNA isolation followed by deep sequencing
Total RNA was extracted from 24 h TPC1 co-cultured macro-
phages and 24 h RPMI cultured monocyte controls (four
donors) after 4 h and 24 h of additional incubation in RPMI
only, using RNeasy Mini and Microkits (Qiagen). 50 ng of
RNA was converted into cDNA libraries according to the Tru-
Seq RNA library preparation kit v2 and libraries were
sequenced on the HiSeq 1500 system and demultiplexed using
CASAVA v1.8 (Illumina). Detail of the further analysis can be
found in the Supplementary data. The detailed data have been
Figure 5. Soluble tumor-derived signals change the phenotype of the tumor-associated macrophage, by induction of the mTOR pathway and glycolysis, and epigenetic
changes.
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deposited in the GEO database with accession number
GSE76445.
Cytokine, chemokine, VEGF, and lactate production
Interleukin 6 (IL-6), IL-8 (Sanquin, Amsterdam, Netherlands),
tumor necrosis factor a (TNF-a, R&D, the Netherlands) con-
centrations in the culture supernatant were measured by com-
mercial ELISA kits according to the instruction of the
manufacturer. GM-CSF, MCP1, and VEGF (all Bio-rad,
Veenendaal, the Netherlands) were measured by Magpix
(Luminex Corporation). Lactate was measured by a Lactate
Fluorometric Assay Kit (Biovision, CA, USA).
Metabolic assays using the seahorse system
TC-induced macrophages were cultured as described above and
after 24 h detached with Versene (ThermoFisher Scientiﬁc)
from the culture plates. 1 £ 105 cells in triplicate were plated
onto overnight-calibrated cartridges in assay medium (RPMI
with 0.6 mM glutamine, pH adjusted to 7.4. For OCR also
5 mM glucose and 1 mM pyruvate was added) and incubated
for 1 h in a non-CO2 corrected incubator at 37

C. OCR and
ECAR were analyzed using a cell mito stress (OCR) or glycoly-
sis stress test (ECAR) kit in a XFp analyzer (Seahorse biosci-
ence, Copenhagen, Denmark) with ﬁnal concentrations of
1 mM oligomycin, 1 mM FCCP, 0.5 mM Rotenone/Antimycin
A, 10 mM glucose, and 50 mM 2-DG.
Western blot assessments
TC-induced macrophages were cultured as described above and
lysed after 24 h being relieved from the tumor cells. Total pro-
tein amounts were determined by BCA assay (Thermo Fisher
Scientiﬁc) and equal amounts of proteins were loaded on pre-
casted 4–15% gels (Biorad, CA, USA). The separated proteins
were transferred to a nitrocellulose membrane (Biorad), which
was blocked in 5% BSA (Sigma). Incubation overnight at 4

C
with rabbit polyclonal antibodies against p-S6K, p-4EBP1, p-
mTOR (Cell Signaling, Danvers, MA, USA), and actin (Sigma)
were used to determine the protein expression, which was visu-
alized using a polyclonal secondary antibody (Dako, Belgium)
and SuperSignal West Femto Substrate (Thermo Fisher Scien-
tiﬁc) or ECL (Biorad).
Chromatin immunoprecipitation (ChIP)
Cells were isolated and cultured as described above. After being
relieved 24 h from the TPC1 cells, TC-induced macrophages
were detached from the plate with 500 mL Trypsin per well and
ﬁxed in methanol-free 1% formaldehyde and stored at 4C
until further processing. Fixed cells were sonicated for 10 min
in a Bioruptor pico sonicator (Diagenode, Seraing, Belgium).
Immunoprecipitation was performed using antibodies against
H3K4me3 and H3K9me3 (Diagenode, Seraing, Belgium). After
ChIP, DNA was processed further for qPCR analysis using the
SYBR green method. Samples were analyzed by a comparative
Ct method. Primer sequences can be found in S1 Appendix.
Immunohistochemistry
Glycolytic enzymes third human isoform of 6-phosphofructo-
2-kinase/fructose-2,6-bisphosphatase and pyruvate kinase 2
(PFKFB3, PKM2), lactate receptor GPR81 and CD68 protein
expression was evaluated by immunohistochemical staining of
formalin-ﬁxed parafﬁn-embedded (FFPE) TC tissue sections.
To remove the parafﬁn, tissues were incubated twice in xylene
and successively in 100%, 96%, and 70% of alcohol for 5 min
each step. Antigens were retrieved with citrate buffer for 2 min
in the microwave (800 W) and 10 minutes at RT (Citrate
buffer: pH D 6.0, 16.4 mL sodium citrate (0.1 M) with 3.6 mL
citric acid (0.1 M) in 180 mL H2O). The endogenous peroxidase
activity was blocked with 3% of H2O2 in methanol for 15 min at
RT. Furthermore, since tumor-like tissues contain endogenous
biotin, this was blocked in the tissue sections by an avidin/bio-
tin blocking kit according to the manufacturers’ protocol (Vec-
tor Laboratories, CA, USA). Sections were incubated with 20%
goat serum diluted in PBS for 10 min and subsequently with
the ﬁrst antibody (PFKFB3 (ab96699, Abcam, 1:100), PKM2
(3198, Cell Signaling, 1:100), GPR81 (ab188647, Abcam, 1:50),
CD68 (KP1, DAKO, 1:8000) all diluted in PBS supplemented
with 5% goat/rabbit serum, overnight at 4C. After washing
with PBS, sections were incubated with a second HRP-conju-
gated antibody 1:200 diluted in PBS for 1 h at RT. The ABC-
HRP complex (ABCkit-HRP Vector PK-6101), 1:500 diluted in
PBS, was applied to the sections for 30 min at RT. The substrate
solution was added for 7 min at RT: 0.5 ml of DAB in 9.5 mL of
PBS and 10 mL of H2O2. Tissues were counterstained with hae-
matoxylin for 30 sec at RT. Slides were dehydrated with conse-
cutive incubation in 70%, 96%, 100% of alcohol and xylene
(two times) for 50 each step. Sections were mounted in
Permount.
Statistical analysis
Differences in cytokine, lactate, VEGF production, trimetyla-
tion, and phosphorylation were analyzed using Wilcoxon
signed-rank test. All analyses were performed in Graphpad
prism 5 (CA, USA). p < 0.05, p < 0.01. Data are shown as
means § SEM. Information on additional statistical analyses
can be found in the supplementary data.
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